COX-2 inhibitors selectively block prostacyclin synthesis in endotoxin-exposed vascular smooth muscle cells.

The FASEB journal : official publication of the Federation of American Societies for Experimental Biology

Volumn 18, Issue 6, 2004, Pages 757-759

  Schildknecht, Stefan ^a   Bachschmid, Markus ^a   Baumann, Achim ^a   Ullrich, Volker ^a  

^a UNIVERSITY OF KONSTANZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

6 OXOPROSTAGLANDIN F1 ALPHA; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; CYTOCHROME P450; ISOENZYME; ISOMERASE; LIPOPOLYSACCHARIDE; NITRIC OXIDE SYNTHASE; PROSTACYCLIN; PROSTACYCLIN SYNTHASE; PROSTAGLANDIN SYNTHASE; PROSTAGLANDIN SYNTHASE INHIBITOR;

ANIMAL; ARTICLE; BIOSYNTHESIS; CATTLE; CYTOLOGY; DRUG EFFECT; ENZYMOLOGY; METABOLISM; VASCULAR SMOOTH MUSCLE;

6-KETOPROSTAGLANDIN F1 ALPHA; ANIMALS; CATTLE; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; CYTOCHROME P-450 ENZYME SYSTEM; EPOPROSTENOL; INTRAMOLECULAR OXIDOREDUCTASES; ISOENZYMES; LIPOPOLYSACCHARIDES; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE SYNTHASE; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES;

EID: 3042742807     PISSN: None     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.03-0609fje     Document Type: Article

References (0)